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The Impact of Depression and Pain Catastrophization
on Initial Presentation and Treatment Outcomes
for Atraumatic Hand Conditions
Daniel A. London, BA, Jeffrey G. Stepan, BS, Martin I. Boyer, MD, FRCS(C), and Ryan P. Calfee, MD, MSc
Investigation performed at Washington University, St. Louis, Missouri
Background: Prior studies have suggested that patient-rated hand function is impacted by depression and pain cata-
strophization. We studied the impact that these comorbidities have on treatment outcomes.
Methods: Two hundred and fifty-six patients presenting to an orthopaedic hand clinic were followed in this prospective
cohort investigation. Patients who were prescribed treatment for atraumatic hand/wrist conditions were eligible for inclusion.
At enrollment, all patients completed the Center for Epidemiologic Studies Depression (CES-D) scale, the Pain Cata-
strophizing Scale (PCS), and theMichigan Hand Outcomes Questionnaire (MHQ; scale of 0 to 100, with 100 indicating the
best hand performance). One month and three months after treatment, patients again completed the MHQ. Participants’
psychological comorbidity status was categorized as either affected (a CES-D score of ‡16, indicating depression, or a
PCS score of ‡30, indicating catastrophization) or unaffected (a CES-D score of <16 and a PCS score of <30). Diagnoses
and treatments for both the affected and unaffected groups were examined. The effect of time and patient status, and
their interaction, on MHQ scores was evaluated by mixed modeling.
Results: Fifty patients were categorized as affected and 206 as unaffected. Diagnoses and treatments differedminimally
between the two groups. At the time of enrollment, themeanMHQ score of the unaffected group (64.9; 95% confidence interval
[CI], 62.5 to 67.3) was significantly higher than that of the affected group (48.1; 95% CI, 43.3 to 53.0). Both groups
demonstrated similar significant absolute improvement over baseline at three months after treatment (an increase of
12.5 points [95% CI, 7.5 to 17.4] in the affected group and 12.8 points [95% CI, 10.4 to 15.3] in the unaffected group).
Thus, at the time of final follow-up, the rating of hand function by the affected patients (60.6 [95% CI, 55.0 to 66.2]) was
still significantly poorer than the rating by the unaffected patients (77.7 [95% CI, 75.0 to 80.5]).
Conclusions: Although patients affected by depression and/or pain catastrophization reported worse self-rated hand
function at baseline and at the time of follow-up, these patients showed similar absolute improvement in self-rated hand
function following treatment compared with patients with unaffected status.
Level of Evidence: Prognostic Level I. See Instructions for Authors for a complete description of levels of evidence.
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D
epression affects 9.1% of individuals in the United
States1. More concerning, the estimated prevalence of
depression increased 60% from 2005 to 20082. Depres-
sion can affect people’s interpretation of pain and negatively
influence their experience with physical health problems and
physical function3-6. The prevalence of depression is believed
to be even higher among all orthopaedic patients compared
with the general population7-10. Furthermore, any orthopaedic
patient is at substantial risk for depression—either its onset or
its unmasking—regardless of the severity of the orthopaedic
presentation7,11,12.
Often intermixed with depression is pain catastrophiza-
tion, which also influences the perception of pain and function.
Catastrophization is defined as an exaggerated or inappropriate
response to nociception, including elements of rumination, mag-
nification, and helplessness13-17, and it predicts the transforma-
tion of acute pain episodes into persisting, chronic issues18,19.
With emotional distress playing a key role in both depression
and pain catastrophization, it is not surprising that these two
psychological morbidities have been correlated14,20-24. As coexisting
conditions, depression and pain catastrophization are impor-
tant psychological comorbidities among patients with disabling
physical pain5,25 and have an additive and adverse effect on people’s
interpretation of physical pain4. They are also predictive of persisting
pain and general musculoskeletal complaints at the time of follow-
up appointments six months after orthopaedic treatment3,26,27.
In orthopaedics, few studies have examined the effects
of these psychological comorbidities—depression and pain
catastrophization—on patient-rated outcome measures for upper-
extremity musculoskeletal injuries. Depression and pain
catastrophization scores, as measured with the Center for Epi-
demiologic Studies Depression (CES-D) scale and the Pain
Catastrophizing Scale (PCS), are strongly and negatively cor-
related with patient-rated upper-extremity function as as-
sessed with use of the Disabilities of the Arm, Shoulder and
Hand (DASH) questionnaire3,5,25,28,29. However, prior investi-
gations on this effect in hand surgery have mostly focused on
cross-sectional data without considering change in patient-rated
outcomes over time25,29-32.
This study was designed to determine the impact of de-
pression (as measured with use of the CES-D) and pain cata-
strophization (measured with use of the PCS) on patient-rated
hand function as assessed using a hand-specific measure (the
Michigan Hand Outcomes Questionnaire [MHQ]) both before
orthopaedic treatment and after (one and three months following
treatment). Our primary hypothesis was that patients affected
by these mental comorbidities would have a worse patient-rated
assessment of their hand function at baseline and following
treatment (one and three months) compared with unaffected
patients. Our secondary aim was to determine the absolute effect
of depression and pain catastrophization on patient-rated response
to treatment for hand conditions. We hypothesized that patients
who were affected by depression and pain catastrophization would
demonstrate a response to treatment at three months, as mea-
sured by absolute change in MHQ score from baseline, that was
equal to the response to treatment of unaffected patients.
Materials and Methods
We obtained institutional review board approval prior to conducting thisprospective cohort study at our tertiary medical center. We recruited
patients from four orthopaedic hand clinics at our institution. For inclusion,
patients were required to be over the age of eighteen years and proficient in
English and to have had an atraumatic diagnosis, regardless of prescribed treat-
ment. Patients presenting with acute traumatic conditions or with expected follow-
up outside our institution were excluded.
Patients were offered participation in this observational study after being
assessed by the physician and were provided with appropriate orthopaedic treat-
ment, which included bracing, medication, corticosteroid injection, referral to
occupational therapy, or surgery. After providing written consent, participants
completed three initial assessments, from which baseline data were obtained. To
assess depression, patients completed the twenty-question CES-D scale (a scale
of 0 to 60, with 60 indicating the highest depressive symptomatology)
33-36
. To
assess pain catastrophization, subjects completed the thirteen-question PCS
(a scale of 0 to 52, with 52 indicating the highest catastrophizing behavior)
13,37
.
Both of these scales were chosen because they have been previously validated
and used in similar studies
5,25,28,34-39
. To assess hand function, subjects com-
pleted the seventy-one-question MHQ (a scale of 0 to 100, with 100 indicating
the best hand performance), which was chosen because it distinguishes the left
and right hand and includes subscales
40-50
. Patient demographic information
collected included date of birth, sex, ethnic and racial background, self-report
of clinically diagnosed depression, whether the patient was currently receiving
treatment for depression, and contact information.
All patients provided follow-up data at two time points: one-month
(± one week) after receiving treatment and three months (± two weeks) after
receiving treatment. At each of these time points, patients completed the MHQ.
We also collected data regarding subjects’ diagnosis(es) and treatment(s). Study
data were collected and managed using REDCap (Research Electronic Data




The chosen sample size was determined a priori using the following data. We
estimated a 20% prevalence of depression and pain catastrophization in our
patients (based on other orthopaedic reports
7-10
). We planned to enroll all
patients who met our inclusion criteria consecutively until fifty patients affected
by depression and/or catastrophization were enrolled and then continue en-
rollment if needed to reach a case-control ratio of 1:4. The 1:4 subject-to-
control ratio (fifty affected, 200 unaffected) was chosen because little additional
power is gained from higher ratios
53
. Published data suggest that the average
MHQ score (and standard deviation [SD]) for patients with a hand condition is
47.4 ± 18.7
43
and estimate a minimal clinically important difference in score,
ranging from 6 to 23 points
48,54
. This sample size provided a power of 0.94 to
detect a 10-point difference in the MHQ score, based on analysis by repeated-
measures ANOVA (analysis of variance). This same sample size provided a power
greater than 0.99 to detect a 20-point difference in the MHQ score by repeated-
measures ANOVA. For our actual analysis methods (see below), we gained
additional power by accounting for the unequal time periods between data
collections by performing a mixed model, which makes the above power and
effect size estimates slightly conservative.
Data Analysis
Participants were categorized into one of two groups defining their psychological
comorbidity status according to baseline data. The affected group was defined
as subjects who, at baseline, had either a CES-D score of ‡1635,36 or a PCS score
of ‡3037. These cutoffs were determined by the creators of the scales and were
subsequently validated as being indicative of depression and pain catastrophization,
respectively
34,36,37,55-57
. Furthermore, these cutoffs are consistent with those presented
elsewhere in the orthopaedic literature investigating this topic
25
. The unaffected
group had, at baseline, both a CES-D score of <16 and a PCS score of <30. We
anticipated moderate correlation between CES-D and PCS scores
4
.
Descriptive statistical analysis was performed on the demographic vari-
ables for both groups. Associations between groups and diagnosis, treatment, and
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the dichotomization of treatment into either surgical or nonsurgical treatment
were assessed by Fisher exact tests. The correlation of CES-D and PCS scores
was determined with use of the Spearman r value. A mixed model was fit to
determine the effect that patient status (i.e., affected versus unaffected), time,
and their potential interaction had on overall MHQ scores. This model took
into account the repeated nature of the data and the unequal time intervals of
data collection. All 95% confidence intervals (CIs) underwent a Bonferroni
adjustment to account for multiple comparisons. A priori contrasts examined
the difference in overall MHQ scores from three months to baseline for both
groups as well as the difference in improvement during this duration between
the two groups. Secondary analyses compared the MHQ subscale scores between
groups as well as determined the impact of surgical versus nonsurgical treat-
ment on overall MHQ scores with use of the same mixed-model methodology.
For all comparisons, significance was defined as p < 0.05. There were no missing
data among the final cohort contributing to our analyses.
Source of Funding
This work was supported by a grant from the Doris Duke Charitable Foundation to
Washington University to fund Doris Duke Clinical Research Fellow Daniel London.
This publication was supported by the Washington University Institute
of Clinical and Translational Sciences grant UL1 TR000448, sub-award TL1
TR000449, from the National Center for Advancing Translational Sciences.
TABLE I Demographic Characteristics
Patient Status
Variable Unaffected (N = 206) Affected (N = 50)
Mean age ± SD at enrollment (yr) 56.9 ± 12.8 53.8 ± 11.5
Sex (no. [%])
Female 144 (69.9%) 37 (74.0%)
Male 62 (30.1%) 13 (26.0%)
Race (no. [%])
African-American 36 (17.5%) 8 (16.0%)
Caucasian 166 (80.6%) 42 (84.0%)
Native American 2 (1.0%) 0 (0.0%)
Other 2 (1.0%) 0 (0.0%)
Depression history (no. [%])
History of depression 31 (15.0%) 33 (66.0%)
Current treatment for depression 21 (10.2%) 26 (52.0%)
Diagnosis (no. [%])
Arthritis 51 (24.8%) 14 (28.0%)
Cyst/mass 14 (6.8%) 0 (0.0%)
Dupuytren disease 10 (4.9%) 2 (4.0%)
Nerve compression 35 (17.0%) 14 (28.0%)
Tendinitis 74 (35.9%) 9 (18.0%)
Ulnar-sided wrist pain 5 (2.4%) 2 (4.0%)
Arthritis and tendinitis 5 (2.4%) 2 (4.0%)
Nerve compression and tendinitis 8 (3.9%) 4 (8.0%)
Other 4 (1.9%) 3 (6.0%)
Treatment (no. [%])
Aponeurotomy 9 (4.4%) 2 (4.0%)
Brace/medication/therapy 52 (25.2%) 19 (38.0%)
Injection 97 (47.1%) 16 (32.0%)
Surgery 47 (22.8%) 13 (26.0%)
Other 1 (0.5%) 0 (0.0%)
TABLE II Mean Overall MHQ Scores at the Three Time Points by Patient Status
Unaffected Affected
Mean 95% CI Mean 95% CI
Baseline 64.9 62.5-67.3 48.1 43.3-53.0
1 mo. after treatment 74.0 71.3-76.8 57.1 51.6-62.7
3 mo. after treatment 77.7 75.0-80.5 60.6 55.0-66.2
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Results
Three hundred and twenty-nine patients were initially approachedto participate in this study. Of those patients, 279 fully com-
pleted the first set of measures—the CES-D, the PCS, and the
MHQ. Two hundred and fifty-six of the 279 patients completed
all follow-up assessments and were included in the final data
analysis (a 92% retention rate) (Fig. 1). The twenty-three patients
who dropped out were not disproportionately members of either
patient group (affected versus unaffected, p= 0.07). As expected,
CES-D and PCS scores were moderately correlated (rs = 0.54)
58.
The distribution of demographic data, diagnoses, and
treatments among the final 256 patients according to group
TABLE III Mean Change in Subscale Scores by Patient Status
Change in Score from Baseline
to One Month
Change in Score from Baseline
to Three Months
Subscale Unaffected Affected Unaffected Affected
Overall hand function 8.1 8.4 11.9 11.9
Activities of daily living 4.5 4.2 9.7 10.1
Work performance 2.6 1.9 8.3 9.7
Pain 13.3 13.6 20.8 20.0
Aesthetics 3.5 2.3 4.3 3.9
Satisfaction 22.1 21.3 25.1 24.6
Fig. 1
Aflowchart depicting thenumberof patientswhowereassessed for eligibility,whowereenrolled,who completedallmeasures, andwhowere included in the
final analysis.
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status is presented in Table I. There was an association be-
tween a patient being classified as affected and both having a
self-reported history of depression (p < 0.001) and being cur-
rently treated for depression (p < 0.001). However, these latter
categorizations did not identify all patients with affected status.
The diagnoses of the patients differed between groups, largely
because of the lack of affected patients who were diagnosed with
a cyst or mass (p = 0.028). However, there was no significant
difference between the groups on the basis of treatment (p = 0.26).
When the treatment variable was categorized as surgical versus
nonsurgical intervention, a lack of a significant difference was
maintained (p = 0.64).
Overall MHQ scores of the unaffected group were sig-
nificantly higher than the MHQ scores of the affected group at
all three time points (Table II). The unaffected group reported
better function, with a significant increase of 12.8 points in
overall MHQ score from baseline to three months (95%
CI, 10.4 to 15.3, t = 10.41, p < 0.001). The affected group
also reported better function, with a significant increase of
12.5 points in overall MHQ score from baseline to three
months (95% CI, 7.5 to 17.4, t = 4.97, p < 0.001). Both groups
equivalently improved their MHQ scores over time, as the
difference in improvement between the groups was not sig-
nificant (0.5 ± 2.8 points [standard error of the mean]; t = 0.15,
p = 0.88). The interaction between psychological comorbidity
status and time was not a significant predictor of overall MHQ
score (F = 0.01, p = 0.99). This result can be seen in Figure 2,
where the MHQ score trajectories are similar for both groups.
However, both a patient’s status (F = 48.03, p < 0.001) and time
(F = 39.87, p < 0.001) were each independently significant
predictors of overall MHQ scores.
The patterns of improved function, stratified by group,
were consistent for all six of the MHQ subscales. Table III reports
the mean change in subscale scores from baseline to one month
and from baseline to three months after treatment. Figure 3 depicts
the similar pattern of change observed over time.
Regardless of psychological comorbidity status, nonsur-
gical patients showed significant improvement from base-
line to one month but nonsignificant improvement from one
month to three months. Among surgical patients who were
unaffected by depression and/or pain catastrophization, the
improvement from baseline to one month was not significant
TABLE IV Overall MHQ scores at the Three Time Points by Patient Status and Type of Treatment
Time Point
Baseline 1 Mo. 3 Mo.
Patient Status Treatment Mean 95% CI Mean 95% CI Mean 95% CI
Affected Nonsurgical (n = 37) 51.4 46.2-56.7 63.4 57.0-69.8 65.5 58.2-72.8
Surgery (n = 13) 38.8 27.4-50.2 39.4 28.6-50.1 46.6 31.2-62.0
Unaffected Nonsurgical (n = 159) 66.8 64.3-69.4 74.0 71.2-76.8 78.7 75.6-81.8
Surgery (n = 47) 58.2 53.3-63.2 62.5 57.1-67.9 74.6 69.2-80.0
Fig. 2
Mean overall MHQ scores at baseline, one month after treatment, and three months after treatment according to patient status (unaffected or affected).
Error bars represent the 95% confidence interval.
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but it was significant from one month to three months. Due
to the small sample size of patients who were both affected
by depression and/or pain catastrophization and underwent
surgery, there were no significant increases from baseline to
three months in overall MHQ scores. Within each treatment
modality, the overall MHQ scores of the unaffected group were
significantly higher than the overall MHQ scores of the affected
group at all three time points. Patterns of improvement, how-
ever, were similar for both the affected and unaffected groups
(Table IV). For all patients, regardless of treatment type, mixed
modeling demonstrated that time and patient status predicted
overall MHQ scores (F ‡ 9.49, all p < 0.001), with no significant
interaction between time and status (p ‡ 0.34).
Discussion
Depression and pain catastrophization can negatively affecthow patients perceive their hand function. Patients with
relatively high scores on the depression or catastrophizing ques-
tionnaires reported clinically worse hand function compared
with patients with relatively low scores on the depression and
catastrophizing questionnaires, before and after treatment, and
regardless of the treatment prescribed. However, both patient
groups had equivalent improvement in patient-rated outcome
scores following treatment. These results suggest that the psy-
chological comorbidities of depression and pain catastroph-
ization, as assessed by the questionnaires we employed, do not
affect patients’ improvement three months after treatment of
atraumatic conditions involving the hand.
When examining patient-rated function prior to treatment,
the orthopaedic literature has demonstrated that psycholog-
ical comorbidities, such as depression and pain catastroph-
ization, impact patients’ perceptions of pain and function,
and these comorbidities correlate with increased levels of pain
and reduced function. Specifically, two prior studies noted that
patients with carpal tunnel syndrome and other atraumatic
hand conditions had increased pain intensity prior to treat-
ment when depression and pain catastrophization were pres-
ent25,32. Our data are consistent with these previous studies.
However, unlike these prior investigations, our longitudinal
data allowed for comparison over time, which demonstrated
similar improvement following treatment among affected and
unaffected patients over a three-month period.
Our findings also corroborate published data suggesting
that depression and pain catastrophization can influence
patient-rated outcomes after intervention for orthopaedic prob-
lems. For example, two weeks after minor hand surgery for
Fig. 3
Mean MHQ subscale scores for overall hand function (Fig. 3-A), activities of daily living (Fig. 3-B), work performance (Fig. 3-C), pain (Fig. 3-D), aesthetics
(Fig. 3-E), and satisfaction (Fig. 3-F) at baseline, one month after treatment, and three months after treatment according to patient status (unaffected =
blue, and affected = red). Error bars represent the 95% confidence interval.
811
TH E J O U R N A L O F B O N E & JO I N T SU R G E RY d J B J S . O R G
VO LU M E 96-A d NU M B E R 10 d M AY 21, 2014
IM PAC T O F DE P R E S S I O N A N D CATA S T R O P H I Z AT I O N O N TR E AT M E N T
OU T C O M E S F O R AT R AU M AT I C HA N D CO N D I T I O N S
carpal tunnel syndrome, trigger fingers, or benign tumors,
patients with higher depressive symptomatology reported
disproportionate levels of pain and had worse postoperative
outcomes as measured with use of the DASH question-
naire28. Similarly, among patients with depression, psycho-
logical status was a predictor of self-reported dissatisfaction
two years after carpal tunnel release30. Analogous results were
seen in a cross-sectional examination of patients treated for
trapeziometacarpal arthritis31. After total knee arthroplasty,
patients demonstrating psychological comorbidities exhibited
worse functional outcome scores and persistent postoperative
pain, from time points that ranged from three months to five
years after surgery59-64. While our data show similar outcomes,
this is only true when three-month MHQ scores are reviewed
in isolation. In contrast to prior studies, our findings indi-
cated that when change in MHQ scores (overall and for the six
subscales) was examined over time, the patients in the affected
group and the patients in the unaffected group responded to
treatment to a similar and clinically relevant extent, regardless
of surgical or nonsurgical treatment. Furthermore, the change
in satisfaction subscale scores did not differ between the two
groups, suggesting that both groups were experiencing the
same change in function based on their own perceptions and
expectations.
While our data are similar to those suggested in the
hand and knee arthroplasty literature, our finding is novel in
that we sought to determine patient response to treatment
after stratification based on psychological status. The existing
hand literature, to our knowledge, focuses on correlational
relationships and cross-sectional methods that do not account
for a patient’s experienced change in function from before to
after treatment. The existing knee arthroplasty literature
investigating this topic focuses on modeling scenarios to
determine what is predictive of poor outcomes, including
depression. While both sets of information are useful, they can
mislead readers into assuming that affected patients, in isola-
tion, have poor outcomes after treatment, and therefore, phy-
sicians may want to modify which treatment options they offer
to that select group. Our data however, indicated that patients
who reported high levels of depression and pain catastroph-
ization on questionnaires reported improvement in MHQ
scores similar in magnitude to unaffected patients after re-
ceiving treatment. Such a finding has relevance when consid-
ering pretreatment counseling of patients. On the basis of our
data, we expect that patients with depression and pain cata-
strophization can still anticipate experiencing clinically mean-
ingful improvement in the months following initiation of
treatment. However, when considering the greater degree of
pain and impairment at baseline, the population affected by
depression and pain catastrophization will, on average, fail to
reach the absolute level of function reported by patients without
those comorbid characteristics.
There are several strengths to our study. First, the large
sample that was analyzed provided greater-than-appropriate
power to test our hypothesis. Bias resulting from missing data
was minimized by our high retention rate (92%) and complete
data collection from the final cohort. Additionally, the inclu-
sion of multiple diagnoses and treatments should allow broad
applicability of our results across atraumatic hand conditions
that present to an orthopaedic hand surgeon’s office.
Not surprisingly, patients’ self-reported history of depression
did not perfectly coincide with CES-D scores categorizing patients as
affected. The CES-D questionnaire states explicitly in its instructions
to answer its questions on the basis of the last seven days. This means
that temporal life events, such as an acute illness, or in the case of our
cohort, hand pain, may impact patient responses such that the score
may not correlate with clinically diagnosed depression. This high-
lights the limitations that are inherent in research that attempts to
study the effect of depression via a questionnaire approach.
An additional limitation is that we defined all events—patient
status, diagnosis, and treatment—on the basis of patient responses
and care provided at or after the first office visit. We did not take
into account a change in patient status, a new diagnosis, or addi-
tional treatment for either the original concern or a new problem.
In doing so, we approached our analysis with a method akin to
intention-to-treat. There was also no placebo group, and conse-
quently, it is not possible to know if the improvement shown by
both groups was due to treatment, the natural course of clinical
presentations, placebo effect, or other unmeasured factors. Ad-
ditionally, with three months of data collection, a response after
treatment is observed; however, longer follow-up may have led
to further differentiation between groups based on long-term
impairment or recurrence rates. We also did not collect any ob-
jective data on patient function; instead, we relied on patient-
rated outcomes, for which it is unclear what effect scaling may
have had. Finally, we cannot be certain what effect, if any, the
complexity of a presenting problem, the nature of previous
treatment experiences, or the tertiary setting of our institution
had on our findings.
It has been hypothesized that assessing patient depres-
sion and pain catastrophization, and treating it, may lead to im-
proved surgical outcomes, limit unnecessary interventions, reduce
pain, and increase quality of life5,11,65,66. Prior studies have dem-
onstrated that treatment of depression and pain catastroph-
ization with cognitive behavioral therapy has led to improved
psychological outcomes and a reduction in pain scores for
patients with chronic back pain, fibromyalgia, temporoman-
dibular pain, and other chronic pain complaints67-75. Additional
studies are warranted to determine if psychological treatment
can result in even greater improvement in patient-rated hand
function for affected patients. n
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